(Q48162038)

9 February 2018

title

Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease (English)

1 reference

9 February 2018

1 reference

1 reference

1 reference

Zhanyun Lv

1

1 reference

9 February 2018

Hong Jiang

2

1 reference

9 February 2018

Huamin Xu

3

1 reference

9 February 2018

Ning Song

4

1 reference

9 February 2018

Junxia Xie

5

1 reference

9 February 2018

publication date

17 June 2010

1 reference

9 February 2018

Journal of Neural Transmission

published in

1 reference

9 February 2018

volume

118

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

361-369

1 reference

9 February 2018

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Relationship of substantia nigra echogenicity and motor function in elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Invited Article: Nervous system pathology in sporadic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Stages in the development of Parkinson's disease-related pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Time course of dopaminergic cell death and changes in iron, ferritin and transferrin levels in the rat substantia nigra after 6-hydroxydopamine (6-OHDA) lesioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Central catecholamine neuron systems: anatomy and physiology of the dopamine systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Treatment with nerve growth factor decreases expression of divalent metal transporter 1 and transferrin receptor in PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Introduction. Oxidative stress in mitochondria disorders of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0434-3

Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments

21 January 2018

1 reference

12 December 2020

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

1 reference

12 December 2020

Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusion bodies in the MPTP-treated squirrel monkey

1 reference

12 December 2020

The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element

1 reference

12 December 2020

Correlation between iron levels and degeneration of dopaminergic neurons in rat nigrostriatal system during the early 6-OHDA lesions in medial forebrain bundle

1 reference

12 December 2020

Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis.

1 reference

12 December 2020

Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography

1 reference

12 December 2020

Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake

1 reference

12 December 2020

Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice

1 reference

12 December 2020

The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.

1 reference

12 December 2020

Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease

1 reference

12 December 2020

alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei.

1 reference

12 December 2020

Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants

1 reference

12 December 2020

Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro

1 reference

12 December 2020

Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization

1 reference

12 December 2020

Iron and ferritin in substantia nigra in Parkinson's disease

1 reference

12 December 2020

Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease

1 reference

12 December 2020

10.1007/S00702-010-0434-3

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018